Mukesh Ambani's 3yr Old Acquisition is finally fighting CANCER!

It’s crazy how impactful Mukesh Ambani’s 3yr old acquisition of Strands Life Sciences has turned out to be 🙏🙏

It’s crazy how impactful Mukesh Ambani’s 3yr old acquisition of Strands Life Sciences has turned out to be 🙏🙏

He acquired a sizable stake in it for Rs 393 crore in Sep 2021. Then increased stake in 2022. And has since poured in hundreds of crores more into it.

But, all this time, there was zero clarity on what all of this money was being spent on and why. The answer is out now.

And, in all humility, we Indians should be grateful that Reliance did what it did.

Let me explain in depth!

Strand Life Sciences was founded in the year 2000, which is over 24yrs ago.

It initially focused on bioinformatics and genomics research, establishing itself as a pioneer in personalized medicine and genetic testing in India.

However, under the Reliance group, Strand began investing massively towards a special project, significantly enhancing its research capabilities, infrastructure, and talent pool.

And now, that investment has culminated in the development of CancerSpot!

..

Wait, what’s that?

A blood test for the early detection of multiple cancer types 🙏🙏

CancerSpot leverages cutting-edge methylation profiling tech to conduct proprietary genome sequencing and analysis on blood samples.

This detects DNA methylation signatures and tumour DNA fragments, offering a non-invasive, simple approach to cancer screening - a gamechanger in early cancer detection.

And this is big for a country like India.

• We are the global cancer capital, with a crazy growth in cancer cases across ages and genders

• And this not only imposes a heavy health burden but also financial, social, and psychological strain on patients and their families

• Practically, for much of India, cancer means, death - because treatment is out of one’s pocket’s reach. And if one does go for a treatment, they end up years behind financially

After all, 95% of India has a per capita which matches the levels of sub-Saharan Africa. Money is a real dealbreaker here 🙏🙏

..

In this context: Early warning is indeed the key in the fight against cancer.

It significantly increases treatment success rates and reduces mortality, all while dramatically bringing down the costs involved.

With Reliance making early detection accessible and way more affordable via Strand, this will potentially save countless lives in years to come and ensure that more and more families end up financially equipped to deal with lower cancer treatment costs in early stages.

And the biggest beneficiary will be 95% of India, as I mentioned above. Thanks to Mukesh Bhai Ambani and family!

Best,
Jayant Mundhra

LinkedIn | Twitter | Instagram | YouTube